Zsofia Laszlo Larue, NP

Zsofia Larue practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Zsofia Larue's NPI, 1295177376, was assigned on July 18, 2013. Zsofia Larue holds California license 95000990.

Zsofia Larue's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Zsofia Larue's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Zsofia Larue is also affiliated with Cedars-Sinai Marina Hospital. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Zsofia Larue to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Zsofia Larue practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Zsofia Larue's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Dmand AI has Zsofia Larue's licenses on file in 2 states: California and District of Columbia.

CMS data shows 28 Medicare services from Zsofia Larue across 1 procedure code in 2024, all of them office visits, for 27 Medicare patients. Medicare paid $693 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 27 Medicare patients who saw Zsofia Larue in 2026. 75% of them have high cholesterol, and 70% have high blood pressure. 41% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Zsofia Larue's median patient age at 70, with 78% women.

In 2026, Zsofia Larue wrote 148 Medicare Part D claims for 50 patients. 87% of them were for generic drugs. CMS names the drug for 58 of them, across 3 drugs with 11 or more claims each, at $747 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Zsofia Larue for performance year 2026, reported as part of a group. Zsofia Larue accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Zsofia Larue as offering telehealth.

CMS Open Payments shows 4 general payments to Zsofia Larue from 4 drug and device companies in 2024. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $103.